Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi Sells 28,759 Shares

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 28,759 shares of the firm’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $30.00, for a total value of $862,770.00. Following the sale, the chief financial officer now directly owns 116,174 shares of the company’s stock, valued at approximately $3,485,220. This represents a 19.84 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Balaji Gandhi also recently made the following trade(s):

• On Monday, January 27th, Balaji Gandhi sold 4,813 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total value of $132,261.24.
• On Tuesday, January 21st, Balaji Gandhi sold 5,827 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total value of $159,135.37.
• On Wednesday, January 15th, Balaji Gandhi sold 836 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total value of $22,555.28.
• On Monday, January 6th, Balaji Gandhi sold 3,195 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total value of $85,018.95.

Phreesia Price Performance

Shares of NYSE:PHR opened at $29.99 on Wednesday. The business has a 50 day moving average price of $26.93 and a 200 day moving average price of $23.68. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $30.53. The company has a market cap of $1.74 billion, a price-to-earnings ratio of -20.40 and a beta of 0.96. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. During the same quarter last year, the company earned ($0.58) EPS. The company’s quarterly revenue was up 16.6% on a year-over-year basis. Research analysts predict that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Institutional Trading of Phreesia

A number of hedge funds have recently modified their holdings of the company. Vanguard Group Inc. lifted its position in shares of Phreesia by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 4,823,110 shares of the company’s stock worth $121,349,000 after acquiring an additional 61,048 shares during the period. Greenhouse Funds LLLP lifted its position in shares of Phreesia by 27.9% in the 4th quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company’s stock worth $72,307,000 after acquiring an additional 626,579 shares during the period. Champlain Investment Partners LLC raised its holdings in shares of Phreesia by 4.1% in the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock worth $57,062,000 after buying an additional 97,847 shares in the last quarter. Franklin Resources Inc. raised its holdings in shares of Phreesia by 0.8% in the 4th quarter. Franklin Resources Inc. now owns 1,509,617 shares of the company’s stock worth $37,982,000 after buying an additional 11,986 shares in the last quarter. Finally, State Street Corp raised its holdings in shares of Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock worth $30,256,000 after buying an additional 88,517 shares in the last quarter. Institutional investors own 92.10% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently issued reports on PHR. Citigroup lifted their price objective on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, January 10th. Needham & Company LLC reiterated a “buy” rating and set a $29.00 price target on shares of Phreesia in a research note on Friday, January 10th. Piper Sandler reiterated an “overweight” rating and set a $33.00 price target (up previously from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. Truist Financial upped their price target on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Finally, JMP Securities reiterated a “market outperform” rating and set a $30.00 price target on shares of Phreesia in a research note on Tuesday, December 10th. Thirteen equities research analysts have rated the stock with a buy rating, According to MarketBeat, Phreesia presently has an average rating of “Buy” and a consensus price target of $31.15.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.